Stay updated on Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.

Latest updates to the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check62 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a clinical trial for chordoma involving nivolumab and relatlimab, while adding a new registry identifier and collaborators, specifically Bristol-Myers Squibb.SummaryDifference59%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check77 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Nivolumab Relatlimab Advanced Chordoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab Advanced Chordoma Clinical Trial page.